Eletriptan Hydrobromide Patent Expiration
Eletriptan Hydrobromide is Used for treating migraines with or without aura. It was first introduced by Upjohn Manufacturing Ireland Unltd
Eletriptan Hydrobromide Patents
Given below is the list of patents protecting Eletriptan Hydrobromide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Relpax | US6110940 | Salts of an anti-migraine indole derivative |
Aug 29, 2017
(Expired) | Upjohn |
| Relpax | US5545644 | Indole derivatives |
Dec 26, 2016
(Expired) | Upjohn |
Eletriptan Hydrobromide's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List